Condition: Relapsed/Refractory Small Cell Lung Cancer · Sponsor: Bristol-Myers Squibb
The purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refractory Small Cell Lung Cancer
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Karmanos Cancer Institute | Detroit, Michigan, United States | Recruiting |
| Local Institution - 0026 | Buffalo, New York, United States | Not Yet Recruiting |
| Duke Cancer Institute | Durham, North Carolina, United States | Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | Recruiting |
| SCRI Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| Local Institution - 0028 | Shanghai Shi, Shanghai Municipality, China | Not Yet Recruiting |
| Istituto Clinico Humanitas | Rozzano, Milano, Italy | Recruiting |
| Local Institution - 0020 | Hirakata, Osaka, Japan | Not Yet Recruiting |
| Local Institution - 0018 | Chuo-ku, Tokyo, Japan | Not Yet Recruiting |
| Oncohelp Medical Center | Timișoara, Timiș County, Romania | Recruiting |
| Local Institution - 0003 | Craiova, Romania | Not Yet Recruiting |
| Local Institution - 0009 | Madrid, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07325136